# Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

> **NCT01986062** · PHASE4 · COMPLETED · sponsor: **Arbor Pharmaceuticals, Inc.** · enrollment: 97 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)

## Interventions

- **DRUG:** AR11
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01986062
- **Lead sponsor:** Arbor Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986062, "Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01986062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*